Scale Computing Reports Q1 Results with Over 40% YoY Growth
New Customer Acquisition more than Doubles as Customers and Partners Seek VMware Alternatives and Edge Computing Solutions INDIANAPOLIS, May 6, 2025 /PRNewswire/... Read more.
Unit4 Launches Ava: the AI Agent for Self-Driving ERP
Advanced Virtual Agent (Ava) is a milestone in journey to automate 50% of ERP tasks LONDON, May 6, 2025 /PRNewswire/ — Unit4, a leader in enterprise cloud... Read more.
Thunderhead Energy Solutions Secures Funding Partnership from Harbert Management Corporation
Strategic partnership will accelerate the deployment of 1,500 Megawatts of behind-the-meter power solutions for data centers AUSTIN, Texas, May 6, 2025 /PRNewswire/... Read more.
Canton Fair: Smart Home Revolution Takes Center Stage
GUANGZHOU, China, May 6, 2025 /PRNewswire/ — “You’ll see a mix of modern international design trends, making it a goldmine for buyers who want... Read more.
Heron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate Updates
Generated Q1 2025 Net Revenue of $38.9 million Delivered record Q1 2025 Adjusted EBITDA of $6.2 million Reached settlement with Mylan Pharmaceuticals, Inc., regarding... Read more.
Galmed Announces First Time Results in Oncology Studies: Aramchol Significantly Enhances Bayer’s Regorafenib Effect in GI Cancer Models
Results from studies at Virginia Commonwealth University (VCU) show that an Aramchol and Bayer’s Regorafenib drug combination significantly reduced hepatic... Read more.
DeFi Technologies Provides Monthly Corporate Update: Valour Reports C$988 Million (US$715 Million) in AUM, and Monthly Net Inflows of C$10.8 Million (US$7.8 Million) in April 2025, Among Other Key Developments
AUM & Continued Monthly Net Inflows: Valour reported assets under management (AUM) of C$988 million (US$715 million) as of April 30, 2025, reflecting an 11.7%... Read more.
Heron Therapeutics Announces Settlement with Mylan Related to CINVANTI® and APONVIE® Patent Litigations
— Company Grants Mylan a License to Market Generic CINVANTI® and APONVIE® Beginning in June 2032 — CARY, N.C., May 6, 2025 /PRNewswire/ — Heron Therapeutics,... Read more.
TransDigm Announces Retirement of Kevin Stein as CEO and Current Co-COO Mike Lisman as Successor
CLEVELAND, May 6, 2025 /PRNewswire/ — TransDigm Group Incorporated (NYSE: TDG) (“TransDigm” or the “Company”) announced today that... Read more.
Bloomberg Expands IBVAL Front Office Pricing to Cover Emerging Market Bonds
IBVAL extends pricing coverage for customers trading liquid securities around the globe and around the clock NEW YORK, May 6, 2025 /PRNewswire/ — Bloomberg... Read more.